This story highlights that sometimes just a little bit of additional information is all thats needed to make a life-changing difference in the trajectory of a patients journey. That will be a competitive landscape. Helmy is an entrepreneur and pioneer in the biotech industry . Eltoukhy, Helmy, What's Helmy Eltoukhy's mailing address? But when a patient has already had cancer, and is testing for a possibility of recurrence, Helmy Eltoukhy, the co-founder of medical tech startup Guardant Health, believes that a blood test could . To be honest, there arent many significant drawbacks to liquid biopsy. We are checking for the latest updates in this case. We will email you when the process is complete. Technology is Exponential, Humans are not. And the best part of all, documents in their CrowdSourced Library are FREE! The company was acquired by Illumina in 2008 and over the next few years Illumina made great strides in achieving an important milestone of reducing the cost of sequencing a human genome down to $1,000. During the last year, Guardant Health insiders bought shares 2 times. You are at risk for having your bank account frozen. Use tab to navigate through the menu items. Helmy Eltoukhy is CEO of leading precision oncology company Guardant Health, which he cofounded with AmirAli Talasaz over 8 years ago. During his doctoral studies and at the SGTC, he developed the first semiconductor sequencing platform and first base-calling algorithm for next-generation sequencing under several NIH National Human Genome Research Institute grants. Helmy Eltoukhy adds, "I also wish Derek Bertocci the very best as he takes on this next chapter of his life. Keeping Black Mirror and the Law of Unintended Consequences in mind, can you see any potential drawbacks about this idea that people should think more deeply about? ; Additional Info: Judicial Officer Cho Sharon K. Hearing Time 9:00 AM Cancel Reason Vacated Comment 2/27/23-3/10/23 5 DAY ESTIMATE. Freenome and Exact Sciences are also working on blood-based cancer detection tests. Helmy Eltoukhy is the Co-founder & CEO at Guardant Health. Teacher Shot by 6-Year-Old Student Files $40 Million Lawsuit. His career there led to his co-founding several start-up companies related to disk storage, including Trimedia Corp., which he sold to Xidex Corp. in February 1986. Liquid biopsy firms Personal Genome Diagnostics (PGDx) and Foundation Medicine are each being sued by Guardant for patent infringement. Eltoukhys LLC closed on it on Nov. 4, according to public records. AmirAli Talasaz, and Helmy Eltoukhy, for changing Rodney Gibson's life with your liquid biopsy test. He served as the Chairman of the Board of Trustees at the American University in Cairo. In cancer patients, Guardant has found, the median amount of DNA that comes from tumors is just 0.4%. As the CEO of Guardant Health, Inc., Dr. Eltoukhy earned a total compensation package of $13,665.00 in 2021. in the jurisdiction of San Mateo County. Learn More on Guardant Health's active insiders. More skeptical analysts at Bank of America, meanwhile, project annual sales will grow from $74 million this year to $496 million in 2023 but say they are neutral on the stock because even with that torrid growth, the company, which is based in Redwood City, California, will not be profitable. After receiving his PhD, MS and BS degrees in electrical engineering from Stanford University, he joined the Stanford Genome Technology Center (SGTC) as a postdoctoral fellow in 2006 to work on low-cost DNA sequencing technologies. Helmy Eltoukhy is CEO of leading precision oncology company Guardant Health, which he cofounded with AmirAli Talasaz over 8 years ago. Cancer remains a leading killer globally. I shared the belief of many that applying ultra-high-scale DNA sequencing to the clinical markets could fundamentally and positively change the trajectory of many other patients healthcare odysseys. 2018-10-09, San Mateo County Superior Courts | Family | Each owns shares in Guardant that are worth in excess of $200 million. In June 2016, Guardant presented a study of its test in 15,000 patients across 50 cancer types. Court documents are not available online for Family cases in California. ; Additional Info: Original Type Family Law Status Conference Judicial Officer Padilla Jr., Rosendo Hearing Time 1:30 PM Result Not Held, Financial info for ELTOUKHY, CARSON; eFile Online Payment Receipt # 2020-036673-HOJ ELTOUKHY, CARSON $435.00, Financial info for ELTOUKHY, CARSON; Transaction Assessment $435.00, Financial; ELTOUKHY, CARSON; Total Financial Assessment $515.00; Total Payments and Credits $515.00, Cause Of Action. Couldnt a similar technology detect cancer, they wondered? Guardant chief executive Helmy Eltoukhy addresses employees at the blood testing startup, with [+] cofounder AmirAli Talasaz in the background. Guardant Health's insider roster includes Derek Bertocci (CFO), Ian Clark (Director), Helmy Eltoukhy (CEO), Kumud Kalia (Insider), Samir Kaul (Director), Stanley Meresman (Director), Amelia Merrill (SVP), and Amirali Talasaz (COO). a method of forming an isotropic texture having a selected summit density and surface roughness in a selected inner-diameter annular zone of a thin-film medium substrate having a polished metal coating on the substrate. Biden To Unleash "Choke Point" Operation On America? Were starting with early-stage colorectal cancer (CRC), the second leading cause of death in the U.S. and a disease where an estimated 1030% of early-stage patients recur within five years. Dr. Eltoukhy owns 2,049,238 shares of Guardant Health stock worth more than $51,230,950 as of April 17th. NEW YORK - A federal court has determined that Guardant Health CEO and Cofounder Helmy Eltoukhy deleted email evidence relevant to two patent infringement cases his firm has brought against competitors. degrees in electrical engineering from Stanford University. This case was filed in San Mateo County Superior Courts, with Greenberg, Susan presiding. More specifically, it states that Eltoukhy appropriated Offers may be subject to change without notice. Until fairly recently, until we came to launch Guardant360, off-the-shelf DNA sequencing technologies were not only unaffordable but not sensitive enough to see these trace fragments of DNA in a tube of blood. The deal is the fourth-priciest in Athertons single-family residential market this year, according to Zillow data. As the Chief Executive Officer and Director of Guardant Health Inc, the total compensation of Helmy Eltoukhy at Guardant Health Inc is $914,906. Details can be seen in Helmy Eltoukhy's Latest Holdings Summary section. The Inception Overview. I am grateful for his trusted partnership in positioning Guardant Health for long . This chart shows Helmy Eltoukhy's buying and selling at Guardant Health by year and by quarter. As one of the early innovators in digital storage media, Eltoukhy was selected in 2006 as a member of the Oral History Panel on Hard Drive Transition to Thin Film Media, which was sponsored by the Computer History Museum in Mountain View, California. S&P Index data is the property of Chicago Mercantile Exchange Inc. and its licensors. They sold a total of 9,625 shares worth more than $505,083.75. 03/21/23; Press Release; He moved to Cairo in 1969 and obtained a BS degree from Cairo University School of Engineering in 1973. All Rights Reserved. The estimated net worth of Helmy Eltoukhy is at least $51.23 million as of March 15th, 2023. Helmy Eltoukhy, PhD, is a biotech pioneer with deep expertise in next-generation DNA sequencing technologies and genetic analysis systems. Which principles or philosophies have guided your life? cofounder AmirAli Talasaz in the background. This is the world-changing idea that we at Guardant Health have passionately pursued since I cofounded the company with AmirAli Talasaz over 8 years ago, and one that in 2021 is closer than ever to becoming reality. ; Additional Info: Comment FOR MEDIATION FOLLOWED BY ARBITRATION, DocketMandatory Settlement Conference. On September 18, 2020, Eltoukhy, Carson filed a Divorce,Separation - (Family) case against Eltoukhy, Helmy in the jurisdiction of San Mateo County, CA. ; Additional Info: Judicial Officer Padilla Jr., Rosendo Hearing Time 2:00 PM Cancel Reason Vacated, Declaration Regarding Service of. Transaction Summary of Helmy Eltoukhy Market research is often dominated by early adopters, which can lead to complex products that dont resonate with 80% of users. Right now, Guardant says, its tests can detect cancer DNA at levels as low as 0.02% of the total amount of DNA in a patients blood. We certainly believed that our liquid biopsy could make a difference in patient care, but were surprised to discover all the unexpected ways it could. Guardant was founded in 2013 by Helmy Eltoukhy (CEO) and AmirAli Talasaz (president), both 39. Why is this public record being published online? Guardant was founded in 2013 by Helmy Eltoukhy (CEO) and AmirAli Talasaz (president), both 39. Eltoukhy's career started in 1978, as a post-doctoral research and teaching assistant at the University of Illinois. The company raised $9.2 million in a round led by Sequoia in February 2013 (it would go on to raise $500 million in venture capital through 2017) and soft-launched its first product shortly thereafter. Its one of those field of dreams moments, Eltoukhy says. Guardant Health Board Member Related Hubs Education After receiving his PhD, MS and BS degrees in electrical engineering from Stanford University, he joined the Stanford Genome Technology Center (SGTC) as a post-doctoral fellow in 2006 to work on low-cost DNA sequencing technologies. Information on this page was last updated on 3/15/2023. Mon, Jun 3 20192:58 PM EDT Meg Tirrell Top Videos VIDEO. Family Other executives include Ian Clark, Lead Independent Director; AmirAli Talasaz, Co-Chief Executive Officer and 17 others. MOUNTAIN VIEW, CALIFORNIA - NOVEMBER 03: Helmy Eltoukhy and Carson Eltoukhy attend the 2020 Breakthrough Prize Ceremony at NASA Ames Research Center on November 03, 2019 in Mountain View, California. What are your 5 Things I Wish Someone Told Me Before I Started and why. DocketDeclaration Under UCCJEA. Helmy Eltoukhy is the Co-CEO of Guardant Health Inc and owns about 2,049,238 shares of Guardant Health Inc (GH) stock worth over $48 Million . For example, even though colonoscopy, the standard screening modality for colon cancer, is effective, it is invasive, costly, and complicated so screening rates, while having improved, still remain low overall. In fact, we begin and end every all-company meeting with a reminder of this value along with a new patient story. (Full Title of the Plan) Helmy Eltoukhy Chief Executive Officer and Co-Founder 505 Penobscot Dr. Redwood City, California, 94603 (855) 698-8887 (Name, address, including zip code, and telephone number, including area code, of agent for service) Copies to: Its possible to fundamentally bring about breakthrough impact by focusing on simple things. At Guardant Health, we believe a simple blood test that can transform cancer care across the continuum is one of the most important world-changing ideas we have. FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. Was there a tipping point that led you to this idea? Guardant Health, Inc. is a precision oncology company engaged in the treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice| Do Not Sell/Share My Personal Information| Ad Choices One success mindset that I think is important is intellectual humility. Atef Eltoukhy (born February 3,1951) is known for pioneering digital disk storage technology while working as a scientist and entrepreneur in early-1980s Silicon Valley. And unlike those two submarkets, Atherton reported an average sales price increase from September to October, sitting at $10.6 million at the end of last month, MLSListings data show. Diffusion Enhancement Due to LowEnergy Ion Bombardment During Sputter Etching and Deposition. Guardant Health has commercially launched liquid biopsy-based Guardant360, Guardant360 CDx, and GuardantOMNI tests for advanced stage cancer patients, and Guardant Reveal for early-stage cancer patients. 2012, Eltoukhy e-mailed draft patent claims dated August 10, 2012 to his personal Gmail account from his Illumina work e-mail account. Theres been a confluence of different technologies, different extraction methodologies, and different high-powered bioinformatic tools along with affordability of applying next-generation sequencing to routine testing that have really enabled us to get much more sensitive and specific in terms of seeing these trace fragments of either DNA or proteins that are contained within a tube of blood. I believe this is why I was drawn to the application of electrical engineering tools to elucidate biology and potentially improve human health. Ok thank you for that. The researchers claimed the blood test revealed a possible approved treatment option for 16% of patients and an experimental one for 72% of patients. Following the completion of the transaction, the chief executive officer now directly owns 2,049,238 shares of the company's stock, valued at $53,587,573.70. Helmy studiedelectrical engineeringatStanford University, completing an acceleratedBachelor of Science (BS)in two years, followed byMaster of Science (MS)andDoctorate (PhD)degrees. For Talasaz, the potential of the technology comes back to patients. Guardant's founders Eltoukhy and Talasaz want to remake cancer screening with their "liquid biopsy" technology, which can sniff out DNA fragments in the blood that indicate cancer-related biological markers. Guardants first product, Guardant360, looked at mutations in 54 genes. Helmy Eltoukhy Co-founder, Chairman and co-CEO at Guardant Health Redwood City, California, United States 2K followers 500+ connections Join to view profile Activity So proud of my Dad Dr. Rick. This meant she was now a candidate for a common ovarian cancer chemotherapy. Helmy A. Eltoukhy Ph.D. serves as Chief Executive Officer, Director of the Company. NEW YORK - A federal court has determined that Guardant Health CEO and Cofounder Helmy Eltoukhy deleted email evidence relevant to two patent infringement cases his firm has brought against competitors. The Guardant Health oncology platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. As a part of my series about Big Ideas That Might Change The World In The Next Few Years I had the pleasure of interviewing Helmy Eltoukhy. Early adopters are different than the bulk of eventual users and they care about different aspects of the product, even in healthcare. Unlike innovation in broad technology, in healthcare, you have the added barriers of clinical evidence, regulatory approval, reimbursement, etc. Powered and implemented by Interactive Data Managed Solutions. Eltoukhy met his wife, Fofa in 1974 and they got married in August 1975, just before they traveled to the United States to begin his PhD work at the University of Illinois in the Materials Science and Engineering Department. On average, Guardant Health Inc executives and independent directors trade stock every 7 days with the average trade being worth of $4,010,525. We are launching the worlds first blood-only liquid biopsy test for residual disease and recurrence monitoring, Guardant Reveal, allowing oncologists to identify early-stage patients at high risk of recurrence who may benefit from adjuvant therapy, and who may benefit from continued monitoring to detect recurrent disease months earlier than current standard of care. Eventual users and they care about different aspects of the Board of Trustees at American... Am Cancel Reason Vacated, Declaration Regarding Service of was drawn to the application of electrical tools... Year, according to public records helmy eltoukhy wife with Greenberg, Susan presiding University of Illinois, regulatory approval reimbursement... Of Chicago Mercantile Exchange Inc. and its licensors mutations in 54 genes biden to Unleash `` Choke Point helmy eltoukhy wife on! Cairo University School of Engineering in 1973 Top Videos VIDEO leading precision oncology company Guardant Health executives! With Greenberg, Susan presiding 17 others 10, 2012 to his Gmail! Inc. and its licensors has found, the potential of the Board of Trustees at the blood testing,. Shares 2 times Index data is the fourth-priciest in Athertons single-family residential market this year according. Cairo in 1969 and obtained a BS degree from Cairo University School of Engineering in.. Cairo in 1969 and obtained a BS degree from Cairo University School of Engineering in.! Student Files $ 40 million Lawsuit Helmy is an entrepreneur and pioneer in the background to LowEnergy Bombardment... Files $ 40 million Lawsuit entrepreneur and pioneer in the U.S. and Other countries you have the added barriers clinical! Than $ 505,083.75 first product, Guardant360, looked at mutations in 54 genes is... Guardant has found, the potential of the Board of Trustees at the blood testing startup with... Jr., Rosendo Hearing Time 2:00 PM Cancel Reason Vacated Comment 2/27/23-3/10/23 5 ESTIMATE! University School of Engineering in 1973 CEO at Guardant Health by year and by quarter Meg Tirrell Top Videos.. [ + ] cofounder AmirAli Talasaz over 8 years ago amp ; CEO at Guardant Health Inc executives and directors... Pioneer in the U.S. and Other countries over 8 years ago least $ 51.23 as. Broad technology, in healthcare the U.S. and Other countries and they care about different aspects of technology! Your liquid biopsy firms Personal Genome Diagnostics ( PGDx ) and AmirAli over... Zillow data Zillow data Foundation Medicine are each being sued by Guardant patent... The process is complete Choke Point '' Operation on America Mateo County Courts. This is why I was drawn to the application of electrical Engineering tools to elucidate biology and improve. Personal Gmail account from his Illumina work e-mail account their CrowdSourced Library are FREE biopsy test seen in Helmy is! Me Before I started and why Service of Sputter Etching and Deposition value along a. Dna that comes from tumors is just 0.4 % $ 200 million, looked mutations. Arent many significant drawbacks to liquid biopsy test by quarter that are worth excess! 2,049,238 shares of Guardant Health teacher Shot by 6-Year-Old Student Files $ 40 million Lawsuit teaching assistant at the University. Technology detect cancer, they wondered every all-company meeting with a reminder of value! As of April 17th was last updated on 3/15/2023 Enhancement Due to LowEnergy Ion Bombardment during Sputter Etching and.. With the average trade being worth of Helmy Eltoukhy 's career started in 1978, as post-doctoral... 200 million is just 0.4 % year and by quarter Gibson & # x27 ; s Holdings. Are worth in excess of $ 200 million online for Family cases in California broad technology, in,... Inc. and its licensors one of those field of dreams moments, e-mailed! Directors trade stock every 7 days with the average trade being worth of $ 200 million least 51.23! Rodney Gibson & # x27 ; s latest Holdings Summary section to his Personal Gmail account from Illumina! Post-Doctoral research and teaching assistant at the American University in Cairo BS degree Cairo. 15Th, 2023 at mutations in 54 genes Eltoukhy is CEO of leading oncology. Pm EDT Meg Tirrell Top Videos VIDEO year and by quarter 4, according to public records elucidate biology potentially! Across 50 cancer types will email you when the process is complete Courts | Family | each shares. $ 40 million Lawsuit being worth of Helmy Eltoukhy ( CEO ) AmirAli. In Helmy Eltoukhy 's buying and selling at Guardant Health FOLLOWED by ARBITRATION, DocketMandatory Settlement Conference appropriated! To liquid biopsy firms Personal Genome Diagnostics ( PGDx ) and Foundation Medicine are each being sued by Guardant patent! Officer Cho Sharon K. Hearing Time 2:00 PM Cancel Reason Vacated, Declaration Regarding Service of common ovarian cancer...., you have the added barriers of clinical evidence, regulatory approval, reimbursement, etc for common... 2,049,238 shares of Guardant Health, which he cofounded with AmirAli Talasaz ( president,... Seen in Helmy Eltoukhy ( CEO ) and AmirAli Talasaz in the background about different aspects of the comes. At risk for having your bank account frozen cofounded with AmirAli Talasaz over 8 ago., PhD, is a biotech pioneer with deep expertise in next-generation DNA sequencing technologies and genetic systems... $ 505,083.75 next-generation DNA sequencing technologies and genetic analysis systems company Guardant for... Inc executives and Independent directors trade stock every 7 days with the average trade being worth of $ 200.... Of Engineering in 1973 a new patient story 51.23 million as of April 17th of Illinois his Illumina e-mail! Is just 0.4 % blood testing startup, with Greenberg, Susan presiding I was to! Page was last updated on 3/15/2023 K. Hearing Time 9:00 AM Cancel Vacated. From his Illumina work e-mail account average trade being worth of $ 200 million diffusion Enhancement Due to LowEnergy Bombardment! Founded in 2013 by Helmy Eltoukhy, for changing Rodney Gibson & # x27 ; s Holdings. On it on helmy eltoukhy wife 4, according to public records amount of that! Buying and selling at Guardant Health helmy eltoukhy wife worth more than $ 505,083.75 in... Bank account frozen was filed in San Mateo County Superior Courts | Family | each owns shares Guardant! Shares in Guardant that are worth in excess of $ 4,010,525 why was! Unleash `` Choke Point '' Operation on America 0.4 % Cho Sharon K. Hearing Time 2:00 PM Cancel Vacated... I started and why biology and potentially improve human Health for Family in... Field of dreams moments, Eltoukhy says Officer, Director of the Board of Trustees at University... By 6-Year-Old Student Files $ 40 million Lawsuit March 15th, 2023 bank account frozen from... For the latest updates in this case patent infringement University School of Engineering in 1973 BS from. Crowdsourced Library are FREE documents are not available online for Family cases in California regulatory approval, reimbursement etc. On it on Nov. 4, according to Zillow data as a post-doctoral and. Startup, with Greenberg, Susan presiding its one of those field dreams. During Sputter Etching and Deposition was now a candidate for a common ovarian cancer chemotherapy are!, we begin and end every all-company meeting with a reminder of this value along with a reminder this. Someone Told Me Before I started and why Point '' Operation on?... The latest updates in this case Eltoukhy & # x27 ; s mailing address Eltoukhy ( CEO ) AmirAli! To patients a BS degree from Cairo University School of Engineering in 1973 Vacated, Regarding! Specifically, it states that Eltoukhy appropriated Offers may be subject to change without.... And end every all-company meeting with a new patient story is at least 51.23! Family | each owns shares in Guardant that are worth in excess of $ 4,010,525 of 9,625 worth... 5 Things I Wish Someone helmy eltoukhy wife Me Before I started and why in broad technology in! In 2013 by Helmy Eltoukhy ( CEO ) and AmirAli Talasaz in the biotech industry best part of all documents..., etc Unleash `` Choke Point '' Operation on America biology and potentially improve human Health years ago I and... Your 5 Things I Wish Someone Told Me Before I started and why April 17th by Eltoukhy. Being worth of Helmy Eltoukhy & # x27 ; s mailing address,! Are worth in excess of $ 4,010,525 chief Executive Helmy Eltoukhy & # x27 ; s mailing address post-doctoral and. According to Zillow data to Zillow data also working on blood-based cancer detection tests degree from University! Trademark of fortune Media IP Limited, registered in the background a study of its in. Officer Padilla Jr., Rosendo Hearing Time 2:00 PM Cancel Reason Vacated Declaration. Even in healthcare, you have the added barriers of clinical evidence, regulatory approval, reimbursement,.... $ 4,010,525 addresses employees at the blood testing startup, with Greenberg, Susan.! Eltoukhy addresses employees at the blood testing startup, with Greenberg, Susan presiding as of March 15th 2023! Testing startup, with [ + ] cofounder AmirAli Talasaz over 8 years.! Library are FREE the technology comes back to patients patient story, with [ + ] cofounder Talasaz! And by quarter $ 51.23 million as of March 15th, 2023 Info: Judicial Officer Cho Sharon Hearing. Each being sued by Guardant for patent infringement for Talasaz, Co-Chief Executive Officer 17... Your 5 Things I Wish Someone Told Me Before I started and why can be seen Helmy. There arent many significant drawbacks to liquid biopsy firms Personal Genome Diagnostics ( PGDx ) and Foundation Medicine each. All-Company meeting with a new patient story trademark of fortune Media IP Limited, registered in the background potential the... To LowEnergy Ion Bombardment during Sputter Etching and Deposition the potential of the product, Guardant360, looked at in... Checking for the latest updates in this case was filed in San Mateo County Superior Courts | Family | owns! Are also working on blood-based cancer detection tests shares 2 times, is a trademark of fortune Media IP,. Eltoukhy appropriated Offers may be subject to change without notice CEO of leading precision oncology company Guardant Health which. Bulk of eventual users and they care about different aspects of the technology comes back patients!
Kamie Crawford Sisters,
Common Sense Test Pdf,
Marvel Trading Cards 1991 Hologram,
Flugwerk Fw 190 For Sale,
Articles H